<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02070224</url>
  </required_header>
  <id_info>
    <org_study_id>PRODIGE</org_study_id>
    <nct_id>NCT02070224</nct_id>
  </id_info>
  <brief_title>Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee Osteoarthritis</brief_title>
  <acronym>PRODIGE</acronym>
  <official_title>Evaluation of the Prognostic Value of Biological Markers, Coll2-1 and Coll2-1NO2 in Patients With Symptomatic Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Artialis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Artialis</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purposes of this study are to assess the prognostic value of serum and urinary biomarkers
      Coll2-1 and Coll2-1NO2 at baseline, and their change over the first year, on the progression
      of knee osteoarthritis MRI scores at 12 months, on the progression of knee osteoarthritis
      clinical score at 12 months. Additionally, this study will search for correlations between
      serum and urinary biomarkers Coll2-1 and Coll2-1NO2 at baseline with the radiographic, MRI
      and clinical severity of knee osteoarthritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRI will be analysed with semiquantitative Whole-Organ Magnetic Resonance Imaging Scoring method (WORMS)</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome Score (KOOS) and Visual Analogue Scales (VAS) for mean knee pain and global patient assessment of disease activity</measure>
    <time_frame>12 month</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Knee prosthesis during the study</measure>
    <time_frame>12 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>MRI cartilage volume (optional)</measure>
    <time_frame>12 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>MRI T2 relaxation time (optional)</measure>
    <time_frame>12 month</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>MRI MOAKS scoring (optional)</measure>
    <time_frame>12 month</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Knee osteoarthritis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serum and urine samples collections</intervention_name>
    <description>Serum and urine samples will be collected at baseline, 3 month, 6 month, 12 month to assess the predictive value of cartilage-specific biomarkers Coll2-1/Coll2-1NO2 on OA progression (MRI, Clinical and radiological progression)</description>
    <arm_group_label>Knee osteoarthritis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Imaging (x-rays and MRI)</intervention_name>
    <description>MRI will be done at baseline and 12 month and x-rays will be done at baseline</description>
    <arm_group_label>Knee osteoarthritis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, aged 45 to 80 years with a BMI ≤ 40

          -  With an uni- or bilateral femorotibial knee osteoarthritis associated or not with a
             femoro-patellar knee osteoarthritis

          -  Responding to clinical and radiological criteria of the ACR

          -  Symptomatic for more than 6 months (for the most painful knee)

          -  K&amp;L radiological grade of Felson II or III

          -  With a cartilage lesion identified during MRI and either at least 1 out of 4 MRI
             severity criteria:

               -  bone oedema

               -  meniscal lesion in the central region of the medial compartment

               -  effusion without answer to corticosteroids

               -  zone without cartilage

          -  or at least 1 out of 3 clinical severity criteria:

               -  genu varum&gt;3°

               -  previous meniscal surgery

               -  known polyarthritis

               -  effusion on the target knee

          -  Sign an informed consent after being informed

          -  Able to follow the instructions of the study

          -  With an agreement from the physicians having established the diagnosis of
             osteoarthritis (if any) to give relevant information to the investigator

          -  With health insurance (for France).

        Exclusion Criteria:

        For osteoarthritis:

          -  Isolated patellofemoral arthritis

          -  Chondromatosis or villo-nodular synovioma of the knee

          -  Recent trauma-induced knee pain

          -  Joint disease due to joint dysplasia, aseptic osteonecrosis, acromegaly, Paget's
             disease, hemophilia, hemochromatosis, …

          -  inflammatory pathologies as rheumatoid polyarthritis, gout arthritis, infectious
             arthritis

          -  Diseases that may interfere with the evaluation of osteoarthritis (radiculalgia of
             lower limbs, arteritis, …)

          -  Genu valgum (degree considered as pathological by the physician)

        For previous treatments:

        • Treatment with strontium ranelate, bisphosphonates, SERM and PTH

        For known associated diseases:

          -  Serious associated diseases: severe liver or renal failure, uncontrolled
             cardiovascular disease, HIV, hepatitis B or C

          -  Knee tumor

        For patients:

          -  Patient who participated to a therapeutic clinical trial 3 months before the T0
             inclusion visit

          -  Patient who are the subject of a judicial protection measure or under guardianship

          -  Pregnant woman

        For MRI contraindications:

          -  Patient with a pacemaker, an implantable defibrillator, neurosurgical clips, a
             neurostimulator, cochlear implant, a stent, an insulin pump

          -  Patient with a ferromagnetic splinter in the body, or having wire sutures

          -  Serious mobility problem (Parkinson, tremors)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Liege-CHU</name>
      <address>
        <city>Liege</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Volders</last_name>
      <phone>+32(0)4 366 72 41</phone>
    </contact>
    <investigator>
      <last_name>Michel Malaise, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of Nancy</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadine Juge</last_name>
      <phone>+33(0)383 15 32 03</phone>
    </contact>
    <investigator>
      <last_name>Damien Loeuille, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2014</study_first_posted>
  <last_update_submitted>January 23, 2017</last_update_submitted>
  <last_update_submitted_qc>January 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

